Please select the option that best describes you:
Topics:
Breast Cancer • Medical Oncology
What is the duration of AI that you use in men with hormone receptor-positive early stage breast cancer?
The MA17R trial only included "postmenopausal women" so how do you make a decision for men and pre-menopausal women.
Answer from: Medical Oncologist at Community Practice
There are no prospectively conducted studies in men with breast cancer. We extrapolate data from adjuvant breast cancer trials with tamoxifen which were conducted in women. Based on some retrospective data, tamoxifen is deemed to be the safe and effective option in men. However, in metastatic breast...
Sign in or Register to read more